US Pharma MarketingCHMP backs Novo’s hemophilia A drug and seven other medicines
CHMP backs Novo Nordisk Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug…
Novo won regulatory backing for its hemophilia A preventive drug from the European Medicines Agency's human medicines committee, which also recommended approving seven other new drugs and 11 label expansions.
The committee gives its opinions ...
Source: Endpoints News